AYTU BIOSCIENCE, INC
ENGLEWOOD, CO · Founded 2015 · CIK 0001385818 · Biotech · Public
small molecule pharmaceuticals for central nervous system diseases
aytubio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $26M
- 7 Form D · Oct 2019
- 84 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 20
- 11 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2008201020122014201620182020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,500 | |
| Private capital raised | Form D · SEC | $10,000 | |
| Private capital raised | Form D · SEC | $4,000 | |
| Private capital raised | Form D · SEC | $2,010,000 | |
| Private capital raised | Form D · SEC | $1,750,000 | |
| Private capital raised | Form D · SEC | $11,839,995 | |
| Private capital raised | Form D · SEC | $10,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1256 | Aardvark Therapeutics, Inc. | — | $103M |
| 1257 | Satellite Biosciences, Inc. | — | $101M |
| 1258 | GPN THERAPEUTICS, INC. | — | — |
| 1259 | AYTU BIOSCIENCE, INC | — | $26M |
| 1260 | NANODESK, LLC | — | — |
| 1261 | CODOMAX INC. | — | — |
| 1262 | Young Biopharma, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Steven BoydDirector
- Gary CantrellDirector
- Jarrett DisbrowExecutive Officer
- Josh DisbrowDirector · Executive Officer
- Joshua DisbrowDirector · Executive Officer
- Carl DockeryDirector
- John Donofrio Jr.Director
- John Donofrio, Jr.Director
- Gregory GouldExecutive Officer
- David GreenExecutive Officer
- Michael MacalusoDirector
- Ketan MehtaDirector
- James` WiegandDirector · Executive Officer
Patents
- Determination Of Fertility Potential From The Oxidation-reduction Potential Of A Biological Samplegranted
- Multiple Layer Gelgranted
- Methods And Systems For Measuring And Using The Oxidation-reduction Potential Of A Biological Samplegranted
- Determination Of Fertility Potential From The Oxidation-reduction Potential Of A Biological Samplegranted
- Measurement and Uses of Oxidative Statusgranted
- Method And Apparatus For Measuring Oxidation-reduction Potentialgranted
- Methods And Systems For Measuring And Using The Oxidation-reduction Potential Of A Biological Sampleapplication
- Use Of Orp For Characterizing Stroke Patientsapplication
- Methods And Systems For Measuring And Using The Oxidation-reduction Potential Of A Biological Samplegranted
- Oxidation-reduction Potential Test Device Including A Multiple Layer Gelgranted
- Methods And Systems For Measuring And Using The Oxidation-reduction Potential Of A Biological Samplegranted
- Method For Improving Animal Food Product Qualityapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.